Satellite Bio

Recent Finacing

Series A

Recent Raise

$110M

Satellite Bio develops implantable Satellites using its Satellite Adaptive Tissue (SAT) platform to program and assemble cells into functional tissues for repair, restoration, or replacement in vivo.

Founded 2019

Massachusetts, United States

11-50

Private

satellite.bio

Highlights

Focus Areas

Biopharma

Biotechnology

Medical

Recent Investors

L

Financials

$110M

Total Raised

1

Funding round

7

Investors

Team

Upgrade to view the team

See the team members at Satellite Bio.